Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Discovery Chemistry Congress

Sir Tom Blundell's Biography

Sir Tom Blundell, Professor, University of Cambridge

Tom Blundell is Sir William Dunn Professor of Biochemistry and Head of Biological Sciences in the University of Cambridge. He researches on structural biology of cell regulation, structural bioinformatics and applications to drug discovery and medicine. He is Member of Academia Europaea, Fellow of the Royal Society and Fellow of Academy of Medical Sciences. He has Honorary Doctorates from fifteen universities. He was a member of ACOST, the advisory group to the PM in the 1980s, founding CEO BBSRC in 1990s and Chairman of the Royal Commission on Environmental Pollution 1998 to 2005. He co-founded Astex Therapeutics, he was Non-Executive Director of Celltech from 1996 to 2005 and has been science advisor to Pfizer, UCB and SKB.

Sir Tom Blundell Image

Structure Guided and Fragment Based Approaches to Drug Discovery to Targeting Protein-Protein Interactions

Wednesday, 14 March 2012 at 09:00

Add to Calendar ▼

Detailed structural knowledge of complexes between macromolecules and their ligands – the structural interactome - can provide a rich source of information on the interaction between biological molecules. I will describe the application of fragment-based approaches to drug targets that involve protein-protein interactions.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonDiscovery Chemistry CongressDiscovery Chemistry Congress in Munich, GermanyMunich,